

# Report on Paper 1: Comorbid Substance Use Disorders

## Abstract: 
This report will generate the information required for the tables and figures of the paper.

## Description of Table 1:
The three races considered and their abbreviations are as follows:
Asian Americans - AA
Native Hawaiian/Pacific Islander - NHPI
Multi-Racial - MR

Other variables of interest are:
Age
Sex
Setting

        
|Race     |Count          |
|---------|---------------| 
|AA       |1510   |
|NHPI     |2707 |
|MR       |7135   |
|**Total**|11352|

### Number of patients grouped by race and age
|Age  |AA|%|NHPI|%|MR|%|
|-----|--|-|-----|-|--|-|
|1-11 |124|8.2|324|12.0|1313|18.4|
|12-17|226|15.0|823|30.4|1274|17.9|
|18-34|540|35.8|726|26.8|1796|25.2|
|35-49|357|23.6|503|18.6|1424|20.0|
|50+  |263|17.4|331|12.2|1328|18.6|

### Number of patients grouped by race and sex
|Sex|AA|%|NHPI|%|MR|%|
|---|--|-|-----|-|--|-|
|Male  |650|43.0|1249|46.1|3191|44.7|
|Female|860|57.0|1458|53.9|3944|55.3|

### Number of patients grouped by race and setting
|Setting|AA|%|NHPI|%|MR|%|
|-------|--|-|-----|-|--|-|
|Hospital            |312|20.7|1745|64.5|594|8.3|
|Mental Health Center|1198|79.3|962|35.5|6541|91.7|
***

    
## Description of Figure 1:
The Axis I/II disorders that are considered and their abbreviations are as follows:
Mood - mood
Anxiety - anxiety
Adjustment - adjustment
ADHD/CD/ODD/DBD - adhd
Substance Use Disorder - sud
Psychotic - psyc
Personality - pers
Childhood-onset - childhood
Impulse-control - impulse
Cognitive - cognitive
Eating - eating
Somatoform - smtf
Dissociation - disso
Sleep - sleep
Factitious Disorders - fd

Disorders with less than 3% prevalence are not shown in the figure

        
![](../results/diagnosesPercentageGraph.png)
***








## Description of Table 2:
This table measures the prevalance of the below among the 3 races, as a percentage of the total or of the various ages:

Any SUD - any_sud
\>=2 SUD - morethan2_sud
Alcohol - alc
Cannabis - cannabis
Amphetamine - amphe
Hallucinogen - halluc
Nicotine - nicotin
Cocaine - cocaine
Opioids - opioids
Sedatives/tranquilizers - sedate
Other drugs - others
Polysubstance - polysub
Inhalants - inhalant

        
### Total Sample
|Prevalence, %       |AA          |NHPI        |MR          |
|--------------------|------------|------------|------------|
|**DSM-IV diagnosis**|**Total = 1510**|**Total = 2707**|**Total = 7135**|
|any_sud               |20.0|21.8|23.9|
|morethan2_sud               |5.5|4.5|7.2|
|alc               |11.2|8.7|8.4|
|cannabis               |6.7|8.2|8.1|
|amphe               |0.9|0.3|0.7|
|halluc               |0.3|0.1|0.1|
|nicotin               |1.6|0.4|2.6|
|cocaine               |2.1|2.0|3.8|
|opioids               |2.6|2.0|5.9|
|sedate               |0.5|0.3|0.8|
|others               |0.3|0.1|0.3|
|polysub               |0.0|0.0|0.0|
|inhalant               |0.5|0.7|0.5|
***


### Asian Americans, separated into age bins
|Prevalence, %       |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|**DSM-IV diagnosis**|**Total: 124**|**Total: 226**|**Total: 540**|**Total: 357**|**Total: 263**|
|any_sud               |0.0|18.1|30.0|19.9|10.6|
|morethan2_sud               |0.0|6.6|8.3|4.8|2.3|
|alc               |0.0|8.4|16.9|10.4|8.4|
|cannabis               |0.0|12.8|9.8|4.5|1.1|
|amphe               |0.0|0.4|1.9|0.8|0.0|
|halluc               |0.0|0.4|0.4|0.3|0.0|
|nicotin               |0.0|0.9|2.4|1.4|1.5|
|cocaine               |0.0|0.0|2.8|3.4|1.9|
|opioids               |0.0|0.4|5.2|2.5|0.4|
|sedate               |0.0|0.4|0.9|0.3|0.0|
|others               |0.0|0.4|0.7|0.0|0.0|
|polysub               |0.0|0.0|0.0|0.0|0.0|
|inhalant               |0.0|0.9|0.9|0.3|0.0|
***


### Native Hawaiians/Pacific Islanders, separated into age bins
|Prevalence, %       |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|**DSM-IV diagnosis**|**Total: 324**|**Total: 823**|**Total: 726**|**Total: 503**|**Total: 331**|
|any_sud               |0.6|17.0|31.7|27.2|24.5|
|morethan2_sud               |0.3|3.2|7.7|5.2|3.6|
|alc               |0.3|3.8|12.8|12.5|14.5|
|cannabis               |0.3|12.2|12.5|5.2|1.5|
|amphe               |0.0|0.1|0.4|0.4|0.6|
|halluc               |0.0|0.1|0.1|0.2|0.3|
|nicotin               |0.0|0.2|0.3|0.6|1.5|
|cocaine               |0.0|0.4|3.2|4.6|1.8|
|opioids               |0.3|0.2|2.2|3.2|5.7|
|sedate               |0.0|0.0|0.4|0.4|1.2|
|others               |0.0|0.0|0.3|0.0|0.3|
|polysub               |0.0|0.0|0.0|0.0|0.0|
|inhalant               |0.0|0.2|2.1|0.6|0.0|
***


### Multi-Racial, separated into age bins
|Prevalence, %       |1-11 y/o            |12-17 y/o           |18-34 y/o           |35-49 y/o           |50+ y/o             |
|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|**DSM-IV diagnosis**|**Total: 1313**|**Total: 1274**|**Total: 1796**|**Total: 1424**|**Total: 1328**|
|any_sud               |0.3|7.8|35.2|38.6|31.5|
|morethan2_sud               |0.0|1.8|10.3|13.4|8.9|
|alc               |0.0|2.0|13.1|13.1|11.3|
|cannabis               |0.1|6.5|18.3|8.4|3.2|
|amphe               |0.0|0.2|2.1|0.5|0.4|
|halluc               |0.0|0.0|0.4|0.0|0.2|
|nicotin               |0.0|0.3|3.5|4.7|4.1|
|cocaine               |0.0|0.0|4.0|8.5|5.8|
|opioids               |0.0|0.1|3.0|12.9|13.9|
|sedate               |0.0|0.2|0.7|1.8|1.5|
|others               |0.0|0.1|0.4|0.7|0.4|
|polysub               |0.0|0.0|0.0|0.0|0.0|
|inhalant               |0.0|0.4|0.9|0.9|0.2|
***